Results from the EMPOWER randomised trial - Sinead Delany-Moretlwe
Themes:
PrEP is a new HIV prevention technology that is likely to benefit adolescent girls and young women (AGYW) in Eastern and Southern Africa at substantial risk for HIV infection. Strategies to support PrEP uptake and address barriers to consistent use are urgently needed. As part of the EMPOWER study, a randomised controlled trial was conducted to evaluate whether empowerment clubs increase PrEP uptake and continuation among AGYW in South Africa and Tanzania.
This Learning Lab presents findings from the trial and shares lessons learned from our experience of delivering combination HIV prevention to adolescent girls and young women.
Sinead Delany-Moretlwe is Associate Professor and Director of Research at Wits RHI. A South African-born medical doctor, her experience is primarily in sexual and reproductive health and HIV prevention research. Currently she is a principal investigator on a large phase III trial of injectable cabotegravir as PrEP, and three demonstration projects of PrEP for adolescent girls and young women, with a particular focus on evaluating interventions that may address the social and structural barriers to PrEP use in young women.
Download a pdf of the presentation here.
